Any pathogenic variation in the LPL gene results in the reduction or absence of LPL activity, resulting in higher TG levels in plasma, which in turn leads to the accumulation of TGs in various tissues resulting in pancreatitis, eruptive xanthomas, and hepatosplenomegaly (25). The gene discussed is LPL; the disease is Hepatosplenomegaly.